TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

James N Kochenderfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.